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Summary
In genome-wide association studies (GWAS), hundreds of thousands of genetic fea-
tures (genes, proteins, etc.) in a given case-control population are tested in favor of
the null hypothesis that there is no association between each genetic marker and a
specific disease. A popular approach in this regard is to estimate local false discov-
ery rate (LFDR), the posterior probability that the null hypothesis is true, given an
observed test statistic. Assuming a certain structure for the underlying model, cov-
ering many situations in genome-wide association studies, we use the method of
moments and introduce a simple, fast and efficient method for LFDR estimation.
We evaluate the performance of the proposed approach by performing two differ-
ent simulation strategies. As well, we examine the practical utility of the proposed
algorithm by analyzing a comprehensive 1000 genomes-based genome-wide asso-
ciation data containing approximately 9.4 million single nucleotide polymorphisms,
and a microarray data set consisting of genetic expression levels for 6033 genes for
prostate cancer patients.
KEYWORDS:
disease association, empirical Bayes, local false discovery rate, method of moments, multiple hypothesis
testing
1 INTRODUCTION
Genetic association studies deal with investigating an association between some disease traits and some genetic features, includ-
ing genes, proteins, lipids and single nucleotide polymorphisms (SNPs). The investigation follows certain strategies to determine
whether there exists some kind of statistical association. In case-control studies, the investigation is started by the determina-
tion of differences between the frequency of alleles or genotypes at genetic marker loci in individuals from a given population.
Significant differences then reflect strong statistical evidence to claim for existence of association. In this paper, we focus on the
analysis of genetic SNP data from population-based genome-wide association studies (GWAS). However, one may apply the
results to other data sets, as long as the underlying model follows the structure considered in this paper.
In GWAS,푁 SNPs (with푁 being usually hundreds of thousands) are genotyped in a given case-control population, and are
tested in favor of the null hypothesis퐻0푖, 푖 = 1,… , 푁 , that there is no association between SNP 푖 and the disease, and against the
alternative hypothesis퐻1푖 that there is such an association in that population. For an individual SNP 푖, the classic statistics deals
with testing퐻0푖 versus퐻1푖 by verifying whether a test statistic 푥푖 falls inside some critical region 훼 , where 훼 is the significance
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level (type-I error or false positive rate). As an example, if 푥푖 represents an estimated allelic odds ratio (OR) for SNP 푖, then a
critical region may be presented by 훼 = {푥푖 ∶ 푥푖 < 휒21;1−훼∕2 or 푥푖 > 휒21;훼∕2}, where 휒21;1−훾 denotes 100(1 − 훾)%-quantile of thechi-square distribution with one degree of freedom. Alternatively, the single hypothesis problem might be tested by comparing
the significance level 훼 with the resulting p-value 푝푖, the smallest value of 훼 such that 푥푖 ∈ 훼 . According to Fisher’s scale
of evidence for interpreting p-values, the less p-value, the more evidence against the null hypothesis 퐻0푖 1. Either way, the
procedure is simple and convenient to use, but the approach leads to a high-rate of false discoveries. To overcome this challenging
situation, several improvements on a set of given p-values have been introduced in the literature, see2,3,4,5 and6. Alternative to
p-value adjustment procedures, is the false discovery rate (FDR) estimation introduced by Benjamini and Hochberg 7 , aiming at
controlling the expected proportion of falsely rejected hypotheses. This seminal work led to many developments. For example,
Storey 8 develops a Bayesian approach for estimating FDR and Efron et. al 9 outline an empirical Bayesian interpretation. The
latter defines FDR as the posterior probability that a null hypothesis퐻0푖 is true given that an observed test statistic 푥푖 falls within
some critical region , i.e., 푃 (퐻0푖 is true|). In case the critical region  consists of only one point, FDR is referred to by the
term Local FDR (LFDR), see Efron 1 and Padilla and Bickel 10 .
In the problem of testing 푁 SNPs against the null hypothesis 퐻0푖, 푖 = 1,… , 푁 , we assume that each of the 푁 SNPs is
unassociated (with some disease) with prior probability 휋0. We further suppose that the test statistic 푥푖 follows a null density,
say 푓0, with chance 휋0 and a non-null density, say 푓1, with chance 휋1 = 1−휋0. Then, LFDR for each SNP 푖 is defined as follows
휓푖 = 푃 (퐻0푖 is true|푥푖) = 휋0푓0(푥푖)푓 (푥푖) , (1)
where 푓 (푥푖) = 휋0푓0(푥푖)+휋1푓1(푥푖). In general 푓0 is assumed to be known (e.g., standard normal density, central chi-square den-
sity with some known degree(s) of freedom, etc.), 푓1 is assumed to be a known density function with some unknown parameter(s)
(e.g., normal density with unknown mean and/or unknown variance, chi-square density with some known/unknown degree(s) of
freedom with some unknown non-centrality parameter, etc.), and 휋0 is an unknown parameter. Such unknown parameters need
to be estimated before making any inferences. Estimated values are then replaced in equation (1) and the resulting estimated
LFDR, say 휓̂푖, is compared to some pre-determined threshold. SNPs not passing the pre-specified threshold are deemed to be
associated with the underlying disease.
Different strategies have been used for LFDR estimation in the literature. Pan et al. 11 and Efron 12,13 perform the estimation
task using a discrete mixture model, and Muralidharan 14 , Padilla and Bickel 10 and Yang et al. 15 use the maximum likelihood
(ML) approach. Bickel 16 summarizes strengths and weakness of classic and empirical Bayes estimation approaches.
In this paper, we assume a certain structure for the underlying model. We assume a multiple hypothesis testing problem in
which 푁 SNPs in a given case-control population are tested in favor of the null hypothesis 퐻0푖, 푖 = 1,… , 푁 , that there is no
association between SNP 푖 and a certain disease. We assume that 휋0, the true proportion of unassociated SNPs, is unknown.
Further, we assume that 푓0 represents a central chi-square density function with some known degree(s) of freedom 휆. We also
assume that 푓1 represents a non-central chi-square density function with 휈 degree(s) of freedom and an unknown non-centrality
parameter 휆. We will discuss in the forthcoming section that these assumptions are not restrictive and are made in many genetic
association studies.
Being concentrated on the chi-square model, Padilla and Bickel 10 as well as Karimnezhad and Bickel 17 assume that the test
statistics 푥푖, 푖 = 1,… , 푁 , are independent and estimate the corresponding LFDR by using the ML approach, i.e.,
휓̂푖 =
휋̂0푓0(푥푖)
휋̂0푓0(푥푖) + (1 − 휋̂0)푓휆̂(푥푖)
, (2)
where
(휋̂0, 휆̂) = arg max휋0∈[0,1],휆∈[푐,푑]
푁∏
푖=1
(
휋0푓0(푥푖) + (1 − 휋0)푓휆(푥푖)
)
, (3)
in which 푐 and 푑 are known bounds. Although this approach leads to somehow sensible estimators, the independency assumption
might be unrealistic in genetic association studies due to linkage disequilibrium (LD). Also, the resulting LFDR estimates highly
depend on the bounds of 푐 and 푑, and inappropriate choices for these bounds can negatively affect the estimation precision. As
another downside, this estimation procedure is time-consuming, and the processing time increases with the number of SNPs as
well as the length on the interval [푐, 푑]. Alternative to this approach, we provide a simple yet efficient algorithm that estimates
LFDRs without assuming independency.We theoretically show that the resulting estimator has a high precision as long as푁 , the
number of SNPs to be tested, is large. Not only is the proposed approach fast, but also it provides an explicit form of estimators
of the proportion rate 휋0 and the non-centrality parameter 휆. As a result, unlike many algorithms including the ML approach
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of Padilla and Bickel 10 and the histogram-based (HB) approach of Efron 1 , it provides an explicit form of the corresponding
LFDR estimator.
The structure of this paper is as follows. In Section 2, we quickly review frequent measures for genetic association studies
used in the literature. We discuss that many genetic association studies reduce to a multiple hypothesis testing problem in a chi-
square model. In Section 3, we present our proposed empirical Bayes approach. Section 4 is devoted to evaluating performance
of the proposed approach. We follow two different simulation strategies and use the mean squared error (MSE) as a common
measure of performance. In Section 5, we apply the proposed approach and analyze two different sets of real data, including a
set of microarray data and another set of coronary artery disease data. We wrap up the paper by providing some discussion and
concluding remarks in Section 6.
2 COMMONMEASURES FOR ASSOCIATION
Consider a diallelic marker locus with a typical allele (wild-type) 퐴 and the alternative (risk) allele 퐵, and let 푝 represent the
frequency of the risk allele, i.e., 푝 = 푃 (퐵) and 1 − 푝 = 푃 (퐴). Denote the corresponding genotypes by 퐺0 = 퐴퐴, 퐺1 = 퐴퐵 and
퐺2 = 퐵퐵 (we do not distinguish between 퐴퐵 and 퐵퐴). Then, genotype frequencies in the population are given by 푔푗 = 푃 (퐺푗),
푗 = 0, 1, 2, where 푔0 = (1 − 푝)2 + 푝(1 − 푝)퐹 , 푔1 = 2푝(1 − 푝)(1 − 퐹 ) and 푔2 = 푝2 + 푝(1 − 푝)퐹 , in which 퐹 is Wright’s
coefficient of inbreeding. For humans, 퐹 is usually taken to be between 0 and 0.05. Under Hardy-Weinberg (HW) equilibrium,
퐹 = 0. Thus, when HW proportions hold in the population, 푔0 = (1 − 푝)2, 푔1 = 2푝(1 − 푝) and 푔2 = 푝2. Let the prevalence
of the disease be 푘 = 푃 (푐푎푠푒), and define 푣푖 = 푃 (푐푎푠푒|퐺푖), the probability of having a disease given a specific genotype at
the marker for genotype 퐺푖, 푖 = 0, 1, 2. Obviously, 푘 = ∑2푖=0 푣푖푔푖. Depending on a chosen genetic model, the penetrances 푣푖have certain relationships with themselves. If the genetic model is additive, then 푣1 = 푣0+푣22 . For recessive, multiplicative anddominant models, 푣1 = 푣0, 푣1 =√푣0푣2 and 푣1 = 푣2, respectively, see Zheng et al. 20 .
Genetic association is usually measured for each individual SNP separately. The data for each SNP can be summarized in
a contingency table of either genotype counts or allele counts by disease status (case or control). Table 1 represents genotype
counts at marker푀 based on a sample of 푟 cases and 푠 controls. Intuitively, the chance of observing genotype 퐺푖 provided that
an individual is known to belong to the case group is estimated by 푟푗
푟
, which is in fact the ML estimate of 푝푗 = 푃 (퐺푗|푐푎푠푒).
Similarly, 푞푗 = 푃 (퐺푗|푐표푛푡푟표푙) is the true chance of having genotype 퐺푖 for a control individual which, with the notations in
Table 1, is estimated by 푠푗
푟
. It is easy to verify using the Bayes principle that 푝푗 = 푣푗푔푗푘 and 푞푗 =
(1−푣푗 )푔푗
1−푘
. Table 2 represents allele
counts at marker푀 based on a sample of 푟 cases and 푠 controls.
Contingency tables play a key role in summarizing genetic association data. Under the null hypothesis that there is no associa-
tion between genotypes in Table 1 (or alleles in Table 2) and the disease, the same relative genotype (or allele) frequencies in both
case and control groups are expected. Contingency tables also allow to summarize data using different models of penetrance.
Perhaps Pearson’s test is the most convenient association test in contingency tables. Pearson’s test statistic for the genotypes in
Table 1 can be presented by
푇푃 =
2∑
푗=0
(푟푗 − 푛푗푟∕푛)2
푛푗푟∕푛
+
2∑
푗=0
(푠푗 − 푛푗푠∕푛)2
푛푗푠∕푛
,
which approximately follows a chi-square distribution with two degrees of freedom. In the same way, the test can be applied
to allele counts in Table 2, and the resulting test statistic approximately follows a chi-square distribution with one degree of
freedom, see Zheng et al. 20 and Clarke et al. 21 among many others. In fact, any test statistic in genetic association studies by
means of a contingency table follows a chi-square distribution with at most two degrees of freedom, see Table 2 of Clarke
et al. 21 . Readers may also refer to Clarke et al. 21 for a summary of strengths and weaknesses of allelic and genotypic tests of
association, as well as the differences between the different models of penetrance.
As an alternative association test, Cochran-Armitage trend (CAT) test is used in situations where some kind of trend in risk
of developing the disease with increasing number of the risk allele in three genotypes is determined. The CAT test assigns some
scores 푤1, 푤2 and 푤3 to the three genotypes 퐺0, 퐺1 and 퐺2 with the condition that 푤0 ≤ 푤1 ≤ 푤2 and 푤0 < 푤2, and looks for
weighted differences between the genotype frequencies in cases and in the union of case and control samples. The corresponding
test statistic is given by
푇퐶 =
[∑2
푗=0푤푗(푟푗푠 − 푠푗푟)
]2
푟푠
푛
[∑2
푗=0푤푗푛푗(푛 − 푛푗) − 2
∑2
푗=1
∑3
푖=푗+1푤푖푤푗푛푖푛푗
] ,
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which under the null hypothesis of no association follows a chi-sqaure distribution with one degree of freedom. The weights푤0,
푤1 and 푤2 are chosen to test a particular type of association. For example, to test whether the allele 퐴 is recessive, the choices
would be 푤0 = 0, 푤1 = 0 and 푤2 = 1. See Clarke et al. 21 and Zheng et al. 20 for more details.
TABLE 1 A typical 2×3 table with 푅 cases and푁 controls.
퐴퐴 퐴퐵 퐵퐵 푇표푡푎푙
Case 푟0 푟1 푟2 푟Control 푠0 푠1 푠2 푠
Total 푛0 푛1 푛2 푛
TABLE 2 Typical allele counts of case-control samples for a single marker
퐴 퐵 푇표푡푎푙
Case 2푟0 + 푟1 2푟2 + 푟1 푟Control 2푠0 + 푠1 2푠2 + 푠1 푠
Total 2푛0 + 푛1 2푛2 + 푛1 푛
Odds ratios (ORs) are another common measure of association between genotypes and diseases. ORs compare the odds of
disease in an individual carrying one genotype to the odds of disease in an individual carrying a different genotype. Thus, for a
diallelic marker, the following two genotypic ORs can be defined
푂푅푖 =
푣푖(1 − 푣0)
푣0(1 − 푣푖)
, 푖 = 1, 2. (4)
푂푅1 compares the odds of disease between individuals carrying genotype 퐴퐵 and those carrying 퐴퐴, and 푂푅2 compares the
odds of disease between individuals carrying genotype 퐵퐵 and those carrying 퐴퐴. In case of no association, 푂푅1 = 푂푅2 = 1.
According to the data in Table 1, ORs can be estimated by 푂̂푅푖 = 푟0푠푖푟푖푠0 with 푉̂ 푎푟(푂̂푅푖) =
1
푟0
+ 1
푟푖
+ 1
푠0
+ 1
푠푖
, 푖 = 1, 2. Then,
푇푂푅푖 =
log 푂̂푅푖 − log푂푅푖√
푉̂ 푎푟(log 푂̂푅푖)
∼ 푁(0, 1), (5)
or equivalently 푇 2푂푅푖 ∼ 휒21 . An OR can also be defined to the allele counts in Table 2. If so, an estimated OR is given by
푂̂푅 = (2푟0+푟1)(2푠2+푠1)
(2푟2+푟1)(2푠0+푠1)
with
푉̂ 푎푟(푂̂푅) = 1
2푟0 + 푟1
+ 1
2푟2 + 푟1
+ 1
2푠0 + 푠1
+ 1
2푠2 + 푠1
. (6)
Similarly, the corresponding test statistic follows a chi-square distribution with one degree of freedom.
A more flexible analysis for GWAS is based on the logistic regression model. Let the binary random variable 푌푖 represent
whether ith individual belongs to the case group (푌푖 = 1) or to the control group (푌푖 = 0), and let 푋푖 denote the genotype
of individual 푖 for an arbitrary SNP so that 푋푖(퐺0) = 0, 푋푖(퐺1) = 1 and 푋푖(퐺2) = 2. Then, the logistic model is defined
as ln 휃푖
1−휃푖
= 훽0 + 훽1푋푖, where 휃푖 = 퐸[푌푖|푋푖] is the expected value of phenotype given a genotype for an arbitrary SNP.
With this setting, the multiple hypothesis testing problem reduces to testing 퐻0푖 ∶ 훽1 = 0 vs 퐻1푖 ∶ 훽1 ≠ 0, 푖 = 1,… , 푁 .
The corresponding test statistic is computed by 푇퐿 = 훽̂1√
푉̂ 푎푟(훽̂1)
. Under the null hypothesis of no association, it follows that
푇퐿 ∼ 푁(0, 1) or equivalently 푇 2퐿 ∼ 휒21 . For details see Padilla and Bickel 10 , Yang et al. 15 and Karimnezhad and Bickel 17 .
3 A NOVEL EMPIRICAL BAYESIAN METHOD
As discussed in the preceding section, many genetic association studies reduce to a multiple hypothesis testing problem in which
the corresponding test statistics follow a chi-square distribution. To conduct such a hypothesis testing problem, we propose to
apply and estimate LFDRs by using a simple and efficient empirical Bayes approach, as we present below.
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Suppose that 푁 SNPs have been genotyped in a case-control population, and that the goal is to test the null hypothesis퐻0푖,
푖 = 1,… , 푁 , indicating that there is no association between SNP 푖 and the disease, against its alternative hypothesis퐻1푖. Suppose
that for each SNP 푖, the test statistic 푥푖 has already been computed using any of the approaches reviewed in the preceding section.
Then, let an indicator variable 휇푖 represent whether 푖th null hypothesis is true in nature, i.e., 퐻0푖 ∶ 휇푖 = 0 and 퐻1푖 ∶ 휇푖 = 1.
Further, let 휋0 ∈ [0, 1] be the true proportion of SNPs not associated with the disease, and define
휇푖 =
{
0 with probability 휋0,
1 with probability 1 − 휋0.
In fact, this indicator variable assigns some chance 휋0 to each null hypothesis to be true. Define 휃 to be a two-state variable so
that it takes 0 if 휇푖 = 0, and takes a positive value 휆 if 휇푖 = 1. Further, assume that the test statistic 푋푖 follows 휒2휈,휃 , the chi-square distribution with 휈 degree(s) of freedom and non-centrality parameter 휃. This model can be expressed by the following
hierarchical model ⎧⎪⎨⎪⎩
푋푖|휃 ∼ 휒2휈,휃 , 푖 = 1,… , 푁,
휃|휇푖 ∼ 휇푖훿휇푖 + 휆훿1−휇푖 ,
휇푖 ∼ 퐵푒푟푛표푢푙푙푖(1 − 휋0),
where
훿푎 =
{
0 if 푎 ≠ 0,
1 if 푎 = 0.
Such a hierarchical Bayes model has already been applied in detecting variants in the analysis of next generation sequencing
data22.
As we reviewed earlier, the degree(s) of freedom 휈 in many genetic association studies reduces to one. Concentration on the
chi-square distribution with one degree of freedom leads to the following nice simplification in LFDR estimation.
Theorem1. Let푋푖, 푖 = 1,… , 푁 , follow the chi-square distributionwith one degree of freedom and the non-centrality parameter
parameter 휆.
(i) The density function of an observation 푥푖 can be expressed by
푓휆(푥푖) =
1
2
√
2휋푥푖
(
푒−
1
2 (
√
푥푖−휆)2 + 푒−
1
2 (
√
푥푖+휆)2
)
.
(ii) Let 푥푖 be an observation from the mixture density 푓 (푥푖) = 휋0푓0(푥푖)+ (1−휋0)푓휆(푥푖). Then, the LFDR based on observing
푥푖 is given by
휓(푥푖) = 휋0
(
휋0 + (1 − 휋0)푒
− 12 휆 cosh(
√
휆푥푖)
)−1
, (7)
and for a given threshold 푢, 휓(푥푖) < 푢 if and only if 푥푖 > ℎ푢(휋0, 휆), where
ℎ푢(휋0, 휆) =
1
휆
[
ln
(
푘푢(휋0, 휆) +
√
푘2푢(휋0, 휆) − 1
)]2
, (8)
with 푘푢(휋0, 휆) = 휋0푒
휆
2
(
푢−1−1
1−휋0
)
.
Proof. The proof is straightforward and hence omitted.
Equation (7) is in fact a simplified version of equation (1) applicable to genetic association studies. In order to be able to
estimate the LFDR, the parameters 휋0 and 휆 in (7) need to be estimated. In this regard, we propose estimating the LFDR using
the method of moment (MM) estimation, which suggests that unknown parameters in a model should be estimated by matching
theoretical moments with the appropriate sample moments23.
Theorem 2. With the setting of Theorem 1, let 푚1 = 1푁
∑
푖푋푖 and 푚2 = 1푁
∑
푖푋2푖 represent the first and the second moments,respectively. Then, MM estimators of 휆 and 휋0 are given by
휆̂ =
푚2 − 3
푚1 − 1
− 6, 휋̂0 = 1 −
푚1 − 1
휆̂
. (9)
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Proof. By using the properties of conditional expectation, observe that
퐸[푋푖] = 퐸휃
[
퐸[푋푖|휃]]
= 1 + 퐸휇푖
[
퐸[휃|휇푖]]
= 1 + (1 − 휋0)퐸휃[휃|휇푖 = 1],
and
퐸[푋2푖 ] = 퐸휃
[
퐸[푋2푖 |휃]]
= 퐸휇푖
[
퐸휃[(휃 + 1)2 + 2(1 + 2휃)|휇푖]]
= 6푚1 − 3 + (1 − 휋0)퐸휃[휃2|휇푖 = 1].
Now, using that fact that 퐸휃[휃|휇푖 = 1] = 휆 and 퐸휃[휃2|휇푖 = 1] = 휆, along with equating the above expectations with the first
and second moments, the above equations lead to (9).
Consistency of the MM estimators23 guarantees that 휆̂ and 휋̂0 converge in probability to 휆 and 휋0, respectively. We show in
the next section that 휆̂ and 휋̂0 estimate the true parameters 휆 and 휋0 very well.
To make an inference regarding association between 푖th SNP and the disease, one may compute the estimated LFDR 휓̂푖 by
replacing estimates of 휆 and 휋0 from equation (9) into equation (7). Therefore, if for a given threshold 푢, 휓̂푖 < 푢, the null
hypothesis퐻0푖 is rejected. Otherwise, there is no evidence of association. An alternative approach would be to replace estimates
of 휆 and 휋0 from equation (9) into ℎ푢(휋0, 휆) in equation (8). Then,퐻0푖 is rejected only if the test statistic 푥푖 is less than ℎ푢(휋̂0, 휆̂).
The second approach is simpler and more convenient, and unlike the existing methods in the literature, it allows for performing
multiple hypothesis testing by just comparing each of the test statistics 푥푖 with a purely data-based threshold. i.e., ℎ푢(휋̂0, 휆̂).
The threshold 푢 in (8) can be chosen according to a subjective belief. A conventional choice would be to choose 푢 = 0.2 to
identifying “interesting cases", see Efron 1 . It also can be chosen based on an objective belief. In this regard, Karimnezhad and
Bickel 17 follow a decision theoretic approach in which for a binary decision rule 훿푖, the null hypothesis퐻0푖 is rejected if 훿푖 = 1,
and is not rejected if 훿푖 = 0. They used the following loss function
퐿(휇푖, 훿푖) =
⎧⎪⎨⎪⎩
0 훿푖 = 휇푖 = 1 or 훿푖 = 휇푖 = 0,
푙퐼 훿푖 = 1, 휇푖 = 0,
푙퐼퐼 훿푖 = 0, 휇푖 = 1,
where 푙퐼 and 푙퐼퐼 are loss values incurred due to making type I and type II errors, respectively. The resulting Bayes estimator of
the parameter 휇푖 is then given by
훿푖 =
⎧⎪⎨⎪⎩
1 if 휓̂푖 ≤ 푙퐼퐼푙퐼+푙퐼퐼 ,
0 if 휓̂푖 >
푙퐼퐼
푙퐼+푙퐼퐼
.
(10)
Now, it can be verified using Theorem 1 that the Bayes rule 훿푖 in equation (10) reduces to the following Bayes rule
훿푢푖 =
{
1 if 푥푖 ≥ ℎ푢(휋̂0, 휆̂),
0 if 푥푖 < ℎ푢(휋̂0, 휆̂),
(11)
with 푢 = 푙퐼퐼
푙퐼+푙퐼퐼
. This Bayes rule is simpler and more convenient than the Bayes rule 훿푖 in equation (10), due to the fact that it is
based on the observed test statistic 푥푖 and estimates of 휋0 and 휆, which are available through the equation (9). In fact, equation
(11) illustrates that, unlike many existing algorithms in the literature, one may perform a multiple hypothesis testing comparison
by just comparing their observed test statistics 푥푖 and the data-based function ℎ푢(휋̂0, 휆̂).
4 SIMULATION
To illustrate the performance of the proposed LFDR estimation approach, we conduct simulations using two different strategies.
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4.1 First simulation study
We follow the simulation strategy used in Karimnezhad and Bickel 17 . We take advantage of the fact that squared of log trans-
formation of OR follows a chi-square distribution with one degree of freedom (see equation (5)), and that as reviewed in Section
2, many algorithms in genetic association studies reduce to a chi-square model with one degree of freedom. For each iteration
in our simulation study, we assume there are a total number of 푁 SNPs to be tested, of which 푁0 SNPs are unassociated. We
generate 푧푖 from 푁(log(푂푅), 휎2)-distribution, where 휎2 is known, and for 푖 = 1,… , 푁0, 푂푅 = 1, and for 푖 = 푁0 + 1,… , 푁 ,
푂푅 ≠ 1. Obviously, 푥푖 = ( 푧푖휎 )2 ∼ 휒21,휆, where for 푖 = 1,… , 푁0, 휆 = 0, and for 푖 = 푁0,… , 푁 , 휆 = log(푂푅). We take the stepsin Algorithm 1.
We carried out different simulations with different parameters. Figures 1a-1b reflect the simulation results based on taking
푁0 = 250, 500, 1000(1000)9000, 9500, 9750, 푁 = 10000, 푛 = 100 and 푂푅 = 1.25, 1.5. Because from (6), variance of OR is
expected to be a very small number, we took 휎2 = 0.01, 0.02. By these choices of OR and 휎2, the true non-centrality parameter(
log(푂푅)
휎
)2 takes one of 2.49, 4.98, 16.44, 8.22 values. From Figure 1a, we observe that for different values of 휋0 (especially when
휋0 ≥ 0.80), 휋̂0 estimates the true 휋0 very well. Remarkably, as the true 휋0 increases, MSE of the corresonding MM estimator
decreases. As well, it is evident from Figure 1b that for different values of 휋0, 휆̂ estimates the true non-centrality parameter 휆
quite well. Although for high values of 휋0, 휆̂ yields to an increase in푀푆퐸휆, 휋̂0 leads to a decrease in푀푆퐸휋0 . However, theMM estimated values of 휋0 and 휆 lead to very low푀푆퐸휓 values, as presented in Figure 2. Also, as observed from this figure,
a decrease in 휎2 or an increase in OR leads to a decreased MSE.
Algorithm 1 First simulation strategy.
Step 1. Specify푁 ,푁0, 푂푅 and 휎2.
Step 2. Take 푗 = 1.
Step 3. Generate 푧1,… , 푧푁0 from푁(0, 휎2)-distribution.
Step 4. Generate 푧푁0+1,… , 푧푁 from푁(log(푂푅), 휎2)-distribution.
Step 5. Compute 푥푖 = ( 푧푖휎 )2, 푖 = 1,… , 푁 , the chi-square test statistics.
Step 6. Compute 휋̂0 and 휆̂ using equation (9).
Step 7. Compute 휓̂1,… , 휓̂푁 by replacing 휋̂0 and 휆̂ into equation (7).
Step 8. Compute errors in estimating 휋0, 휆 and 휓푖 by 퐸푗휋0 = (휋̂0 − 휋0)2, 퐸푗휆0 = (휆̂− 휆)2 and 퐸
푗
휓 =
1
푁
∑푁
푖=1(휓̂푖 −휓푖)
2, respectively.
Step 9. Increase 푗 by one and repeat Steps 3 to 8 for 푛 times. Then, compute
푀푆퐸휋0 =
1
푛
푛∑
푗=1
퐸푗휋0 , 푀푆퐸휆 =
1
푛
푁∑
푗=1
퐸푗휆, 푀푆퐸휓 =
1
푛
푛∑
푗=1
퐸푗휓 .
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FIGURE 1 Plots of (a)푀푆퐸휋0 (b)푀푆퐸휆 for different values of 휋0 in the first simulation strategy.
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FIGURE 2 Plots of푀푆퐸휓 for different values of 휋0 in the first simulation strategy.
4.2 Second simulation study
We simulate case-control samples for each SNP given an additive model. The simulation strategy follows the steps in Algorithm
2. Although this simulation strategy includes more parameters than the first one, it does not allow to control the true parameter
휆. The only true parameter which is known from the beginning of the simulation is 휋0 = 푁0푁 . Thus, in this simulation strategy,
we are only able to measure the accuracy in estimating 휋0. However, since 휆̂ in equation (9) directly depends on the value of 휋̂0,
a perfect estimate of 휋̂0 would automatically lead to a reliable estimate of 휆.
Following the above simulation algorithm, we conducted different simulations with different parameters. We took 푟 = 1000,
푠 = 1000, 푝 = 0.2, 푣0 = 0.01, 푂푅2 = 1.25, 1.5, 2, 푁0 = 250, 500, 1000(1000)9000, 9500, 9750, 푁 = 10000 and 푛 = 100.
Figure 3 represents the accuracy in estimating 휋0. From this figure we observe that the proposed estimator of 휋0 using the MM
approach has a very desirable performance. As discussed above, this convinces that the corresponding non-centrality parameter
휆 was also perfectly estimated. Consequently, the resulting LFDR estimates are highly precise and reliable. As observed from
Figure 3, an increase in OR leads to a decreased MSE, as expected.
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Algorithm 2 Second simulation strategy.
Step 1. Specify the numbers of cases (푟) and controls (푠), the allele frequency 푝 for the risk allele 퐵 and the reference penetrance
푣0.
Step 2. Take 푙 = 1.
Step 3. Take 푂푅2 = 1.
Step 4. Calculate 푣2 using the following equation
푣2 =
푒푥푝(훽0 + 훽2)
1 + 푒푥푝(훽0 + 훽2)
,
where 훽0 = log
(
푣0
1−푣0
)
and 훽2 = log(푂푅2) (the above equation is in fact the prospective logistic regression model).
Step 5. Calculate 푣1 = 12 (푣0 + 푣2) (this is due to selecting ad additive model).
Step 6. Calculate 푘 = ∑2푖=0 푣푗푔푖, where 푔0 = (1 − 푝)2, 푔1 = 2푝(1 − 푝) and 푔2 = 푝2.
Step 7. For 푗 = 1, 2, 3, calculate 푝푗 = 푔푗푣푗∕푘 and 푞푗 = 푔푗(1 − 푣푗)∕(1 − 푘).
Step 8. Take 푚 = 1.
Step 9. Generate random samples (푟0, 푟1, 푠2) and (푠0, 푠1, 푠2) independently from the multinomial distributions푀푢푙(푟; 푝0, 푝1, 푝2)
and푀푢푙(푠; 푞0, 푞1, 푞2), respectively. This leads to a 2 × 3 Table similar to Table 1.
Step 10. Similar to Table 2, construct the corresponding 2×2 Table and compute the chi-square test statistic of independence, i.e.,
푥푙 =
∑4
푗=1(표푗 − 푒푗)
2∕푒푗 , where 표1 = 2푟0 + 푟1, 표2 = 푟1 + 2푟2, 표3 = 2푠0 + 푠1, 표4 = 푠1 + 2푠2, 푒1 = 2푅(2푛0 + 푛1)∕(2(푅+푆)),
푒2 = 2푅(푛1 + 2푛2)∕(2(푅 + 푆)), 푒3 = 2푆(2푛0 + 푛1)∕(2(푅 + 푆)), 푒4 = (2푆)(푛1 + 2푛2)∕(2(푅 + 푆)) with 푅 = 푟0 + 푟1 + 푟2,
푆 = 푠0 + 푠1 + 푠2 and 푛푗 = 푟푗 + 푠푗 , 푗 = 1, 2, 3.
Step 11. Step up 푚 by one and repeat Steps 9-10 until 푚 = 푁0.
Step 12. Take 푂푅2 = 훾 ≠ 1 and repeat Steps 4-7.
Step 13. Increase 푚 by one, and repeat Steps 9-10 until 푚 = 푁 .
Step 14. Estimate 휋0 and 휆 by 휋̂0 and 휆̂ using the generated test statistics 푥1,… , 푥푁 and equation (9).
Step 15. Compute the error of estimating the true proportion of unassociated SNPs by 퐸푙휋0 = (휋̂0 − 휋0)2, where 휋0 =
푁0
푁
.
Step 16. Increase 푙 by one and repeat Steps 3-15 for 푛 times. Then, compute
푀푆퐸휋0 =
1
푛
푛∑
푙=1
퐸푙휋0 .
5 APPLICATIONS
5.1 Application to a microarray data set
In this subsection, we use a prostate data set used by Efron 1 in which genetic expression levels for 6033 genes were obtained
for 102 men including 50 normal control individuals and 52 prostate cancer patients. The interest is to test whether there is any
difference between gene expression level and the prostate and normal individuals, 푖 = 1,… , 6033.
Let 푦̄(1)푖 and 푦̄(2)푖 be the mean of the normal individuals and cancer patients, and suppose that 푠푖 is an estimate of the pooled
sample standard error. To conduct this multiple hypothesis testing problem, the two-sample 푡 test statistics 푡푖 = 푦̄
(1)
푖 −푦̄
(2)
푖
푠푖
need to
be computed first. One may then convert these test statistics to standard normal statistics 푧푖 = Φ−1(퐹100(푡푖)) where Φ and 퐹100
are the cumulative distribution functions of normal and 푡 distributions, respectively. By this transformation, the null hypothesis
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FIGURE 3 Plots of푀푆퐸휋0 for different values of 휋0 in the second simulation strategy.
can be expressed as 퐻0푖 ∶ 푧푖 ∼ 푁(0, 1). Now, to apply our proposed estimation method, it suffices to use the transformation
푥푖 = 푧2푖 . Then, the multiple hypothesis testing problem reduces to testing 퐻0푖 ∶ 푥푖 ∼ 휒21 , and the resulting estimator formequation (9) reduces to 휋̂0 = 0.936. According to Efron 1’s HB approach and with the help of locfdr package24, 휋0 is estimated
to be equal to 0.932, see1, page 71. We also estimated 휋0 using the ML approach of Padilla and Bickel 10 . In this regard, we took
푐 = 0 and 푑 = 10 in equation (3), and applied the LFDR.MLE package of Yang et al. 25 . Table 3 represents estimated values of
휋0 along with processing time on a personal computer (core i7, 3.5 GHz speed with 16 GB of RAM). Remarkably, the difference
between estimates of 휋0 using the HB and MM approaches is ignorable. We also observe that the MM approach is faster than
the other approaches. It is almost 92 and 17 times faster than the ML and HB approaches, respectively.
TABLE 3 Comparison of processing time and estimated 휋0 based on the HB, ML and MM approaches in the prostate data.
Estimation method 휋̂0 processing time (seconds)
HB 0.932 0.069
ML 0.944 0.370
MM 0.936 0.004
5.2 Application to a comprehensive coronary artery disease data set
In this subsection, we apply the proposed LFDR estimation approach to analyze a comprehensive 1000 genomes-based genome-
wide association data analyzed by Nikpay et. al 26 . The data set consists of approximately 185,000 coronary artery disease
(CAD) cases and controls, containing approximately 6.7 million variants with a minor allele frequency of greater than 0.05
and approximately 2.7 million variants with an allele frequency ranging between 0.005 and 0.05. The corresponding publicly
available data consists of 9,455,777 SNPs with different information such as SNP name, chromosome name, effect allele, non-
effect allele, frequency of effect allele, logistic regression coefficient (훽̂) with the corresponding standard deviation (ŝ푒훽̂), andp-value. According to this data set, if p-value was a measure of association, then 2,213 total variants were significantly associated
(p-value is less than 5×10−8). But here we are interested in verifying such association based on estimated LFDRs. To implement
our proposed estimator, for each SNP 푖, we took the test statistic 푥푖 to be
(
훽̂푖
ŝ푒훽푖
)2
. Then, equation (9) with a processing time of
4.385 seconds led to 휋̂0 = 0.9967 and 휆̂ = 21.9274. By these estimates, estimated LFDRs for the 2,213 variants had a maximum
of 0.00032. This suggests that there is strong evidence for the association of the 2,213 SNPs with the CAD.
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Nikpay et. al 26 report ten new loci containing candidate causal genes newly implicating biological processes in vessel walls.
Our analyses revealed that eight of the ten loci lead to estimated LFDRs less than 0.0003, but we are unable to confirm that the
remaining two SNPs (rs11830157 and rs12976411) are associated with CAD.
We also applied the HB and ML approaches to analyze the data. The HB approach failed due to model misfit, and the ML
approach with 푐 = 0 and 푑 = 30 in equation (3) led to a very close 휋̂0 (0.996) to the one reported by the MM approach. However,
the processing time (445.237 seconds) was 339 times slower than the MM approach.
6 DISCUSSION AND CONCLUDING REMARKS
In this paper, we investigated estimating LFDRs for genetic association data. By reviewing well-known measures of association
in the literature, we showed that many of the currently used measures reduce to a chi-square model with one degree of freedom.
We presented a simple LFDR estimation strategy by using the MM estimators of the proportion 휋0 and non-centrality parameter
휆. The approach, as presented in Theorem 2 as well as Section 5, is simple and fast to apply. Also, as demonstrated by the two
simulation strategies in Section 3 and the real data analysis in Section 5, it leads to reliable estimates. On the other hand, the
ML approach of Padilla and Bickel 10 highly depends on the bounds of 푐 and 푑 in (3), is time consuming, and the processing
time increases with the number of SNPs as well as the length on the interval [푐, 푑]. The HB approach of Efron 1 also depends
on some preset parameters such as the number of breaks in the discretization of the 푧-scores, the degrees of freedom for fitting
the estimated density, etc.25, and it may fail due to model misfit.
Our proposed parametric method for estimating false discovery rates relies on the assumption that all non-null features have
the same non-centrality parameter. This might not seem biologically realistic, but there are important advantages behind such
an assumption. This assumption makes the estimation procedure easy and straightforward. Of course, having 푁 different non-
centrality parameters in the model make it more biologically realistic, but that would rise the issue of interpretability. A single
non-centrality parameter in the model is in fact a measure of the detectability of associations27. It can also be interpreted as the
average deviation of the data distributions of SNPs associated with a disease from the data distribution of those unassociated
SNPs15. It is also noteworthy that, according to the results presented in Section 5, having a single non-centrality parameter leads
to an ideal model performance.
It is remarkable that, our proposed approach is similar to the classic hypothesis testing in the sense that the test statistic 푥푖 is
compared to a threshold. However, the threshold in the MM approach is ℎ푢(휋̂0, 휆̂), while in the classic hypothesis testing it is
just a 100(1− 훼
2
)% quantile of the underlying distribution. This ideal property provides a more user-friendly estimator of LFDR
than the other existing approaches.
It is worth adding that, estimating LFDRs in the literature is usually done by using some algorithms without knowing explicit
form of estimators of the underlying parameters. For example, in theML estimation used by Padilla and Bickel 10 , an algorithm is
applied to find arguments that maximize the likelihood function numerically, without providing any closed form of the resulting
estimators of the parameter. Such algorithms may also require some unrealistic assumptions such as independency. On the
contrary, our proposed approach offers explicit forms of estimators of the parameters 휋0 and 휆, without imposing any restriction
to the model. This leads to user-friendly estimators using the simple Bayes rule provided in equation (11). All a user needs is
the test statistics and estimated values of 휋0 and 휆.
As discussed in our second real data analysis, the estimated value of 휋0 using our proposed approach is very close to the one
reported in Efron 1 . Obviously, this compliance confirms that the two approaches estimate 휋0 very well, but this does not mean
that the same threshold of estimated LFDR should be used. This is due to the fact that Efron 1’s LFDR estimation is based on
the normal model while our proposed approach is on the basis of the chi-square model. Thus, if one is interested in using a 0.20
threshold when using Efron’s HB approach, she/he might use a different one (maybe 0.1 or less) when applying our proposed
approach.
The estimation procedure presented in this paper can be used for other purposes, too. For example, Karimnezhad and Bickel 17
introduce LFDR estimation in presence of some additional information such as genetic annotations. They use the ML approach
of Padilla and Bickel 10 but one may be interested in applying our proposed estimation approach in their reference class problem.
If so, new estimators of LFDR will be derived.
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